Search Results

Return to List
Results 1–6 of 6
Sort By: Relevance | Date | Title

Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period

Committee Opinion Number 623, February 2015

(Reaffirmed 2016. Replaces Committee Opinion Number 514, December 2011)

ABSTRACT Acuteonset severe systolic hypertension severe diastolic hypertension or both can occur in pregnant women or women in the postpartum period Introducing standardized evidencebased clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to re...

February 2015

PDF Format

Hospital-Based Triage of Obstetric Patients

Committee Opinion Number 667, July 2016

ABSTRACT Emergency departments typically have structured triage guidelines for health care providers encountering the diverse cases that may present to their units Such guidelines aid in determining which patients must be evaluated promptly and which may wait safely and aid in determining anticipa...

July 2016

PDF Format

Lead Screening During Pregnancy and Lactation

Committee Opinion Number 533, August 2012

(Reaffirmed 2016)

Abstract Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels Adverse effects of lead exposure are being identified at lower levels of exposure than previously recognized in both children and adults In 2010 the Ce...

August 2012

PDF Format

Magnesium Sulfate Use in Obstetrics

Committee Opinion Number 652, January 2016

(Reaffirmed 2016. Replaces Committee Opinion Number 573, September 2013)

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

January 2016

PDF Format

Maternal-Fetal Intervention and Fetal Care Centers

Committee Opinion Number 501, August 2011

(Reaffirmed 2014)

ABSTRACT The past two decades have yielded profound advances in the fields of prenatal diagnosis and fetal intervention Although fetal interventions are driven by a beneficencebased motivation to improve fetal and neonatal outcomes advancement in fetal therapies raises ethical issues surrounding m...

August 2011

PDF Format

Placenta Accreta

Committee Opinion Number 529, July 2012

Reaffirmed 2015

ABSTRACT Placenta accreta is a potentially lifethreatening obstetric condition that requires a multidisciplinary approach to management The incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate Women at greatest risk of placenta accreta are those w...

July 2012

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998